VanEck Biotech ETF (BBH) Stock Price, Quote, News & History

BBHNASDAQ
$236.04
7.403.24%
Last update: Sep 8, 9:29 AM

VanEck Biotech ETF (BBH) Stock Price, Quote, News & History | Benzinga

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Sector
Healthcare
Region
US
AUM
406.09M
Fund Score
Loading...

Key Statistics

Open
$229.48
High
$230.31
52 Wk High
$244.35
AUM
406.09M
Dividend
$1.10
Ex-Div Date
Dec 22, 2025
Volume
2.27K
Market Cap
$87.41B
Mgmt Fee
0.35%
P/E Ratio
21.98
Prev. Close
$228.64
Low
$229.46
52 Wk Low
$160.91
Shares Out
2.65M
Yield
0.48%
Div. Freq
-
Avg. Volume Daily
10.47K
Beta
0.70
Avg. Expense Ratio
0.35%
P/B Ratio
5.20

Recent VanEck Biotech ETF News

FAQ

Q

How do I buy VanEck Biotech ETF (BBH) stock?

A

You can purchase shares of VanEck Biotech ETF (NASDAQ:BBH) through any online brokerage.

View our list of the best stock brokerages

Q

Who are VanEck Biotech ETF (BBH) competitors?

A

There are no as such competitors for VanEck Biotech ETF.

Q

What is the forecast, or price target, for VanEck Biotech ETF (BBH) stock?

A

There is no analysis for VanEck Biotech ETF to provide a consensus price target.

Q

What is the current price for VanEck Biotech ETF (BBH)?

A

The stock price for VanEck Biotech ETF (NASDAQ: BBH) is $236.04 last updated September 8, 2026 at 9:29 AM EDT.

Q

Does VanEck Biotech ETF (BBH) pay a dividend?

A

There are no upcoming dividends for VanEck Biotech ETF.

Q

When is VanEck Biotech ETF (NASDAQ:BBH) reporting earnings?

A

VanEck Biotech ETF does not have any upcoming earnings scheduled.

Q

Is VanEck Biotech ETF (BBH) going to split?

A

There is no upcoming split for VanEck Biotech ETF.

Key Statistics

Open
$229.48
High
$230.31
52 Wk High
$244.35
AUM
406.09M
Dividend
$1.10
Ex-Div Date
Dec 22, 2025
Volume
2.27K
Market Cap
$87.41B
Mgmt Fee
0.35%
P/E Ratio
21.98
Prev. Close
$228.64
Low
$229.46
52 Wk Low
$160.91
Shares Out
2.65M
Yield
0.48%
Div. Freq
-
Avg. Volume Daily
10.47K
Beta
0.70
Avg. Expense Ratio
0.35%
P/B Ratio
5.20

About

Sector
N/A
Industry
N/A
ETF Details
SectorHealthcare
CategoryMid Performer-Mid Growth
Investment StyleLarge Cap Growth
Fund InceptionDec 20, 2011
Managers
Peter H. Liao
Griffin Driscoll
DefinitionMost of the stocks in this equity fund have average financial performance and average growth potential
Investment Policy
The Fund normally invests at least 80 percent of its total assets in securities that comprise the Funds benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. To be initially eligible for the Biotech Index, companies must generate at least 50 percent of their revenues from biotechnology. Biotechnology includes companies engaged primarily in research (including research contractors) and development as well as production, marketing and sales of drugs based on genetic analysis and diagnostic equipment (excluding pharmacies). Of the largest 50 stocks in the biotechnology industry by full market capitalization, the top 25 by free-float market capitalization (i.e., includes only shares that are readily available for trading in the market) and three-month average daily trading volume are included in the Biotech Index.
Top ETF Holdings
SymbolNameShare %
AMGNAmgen Inc.16.6%
VRTXVertex Pharmaceuticals...8.58%
REGNRegeneron Pharmaceutic...7.39%
GILDGilead Sciences Inc12.9%
ASArgenx Se Sponsored Ad...4.49%
IQVIqvia Holdings Inc.5.08%
NTRANatera Inc4.80%
RVMDRevolution Medicines I...5.36%
ILMNIllumina, Inc.3.48%
BIIBBiogen Inc.3.35%